PMV Pharmaceuticals, Inc. (PMVP) Stock Analysis & Investment Frameworks
PMV Pharmaceuticals, Inc. (PMVP) stock analysis on Invetso. Review PMV Pharmaceuticals, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
PMV Pharmaceuticals, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
PMV Pharmaceuticals, Inc. Key Financial Metrics
- Market Cap: $67.20M
- Revenue: $N/A
- ROE: -78.11%
- ROIC: -111.08%
- Dividend Yield: N/A
About PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations. Originally known as PJ Pharmaceuticals, Inc., the firm rebranded to PMV Pharmaceuticals, Inc. in July 2013. The company was founded in 2013 and has its main operational base in Cranbury, New Jersey.
PMV Pharmaceuticals, Inc. Investment Frameworks
Invetso analyzes PMV Pharmaceuticals, Inc. (PMVP) across the following frameworks:
- PMV Pharmaceuticals, Inc. 10Y Growth Potential
- PMV Pharmaceuticals, Inc. Scenario Analysis
- PMV Pharmaceuticals, Inc. Risks & Opportunities
- PMV Pharmaceuticals, Inc. Economic Moat
- PMV Pharmaceuticals, Inc. Business Model
- PMV Pharmaceuticals, Inc. Management
- PMV Pharmaceuticals, Inc. SWOT Analysis
- PMV Pharmaceuticals, Inc. Porter's 5 Forces
- PMV Pharmaceuticals, Inc. PESTLE Analysis
- PMV Pharmaceuticals, Inc. ESG Analysis